Alberta Cancer Exercise Hybrid Effectiveness-Implementation Study (ACE)

July 26, 2023 updated by: University of Alberta

The Alberta Cancer Exercise "ACE" Program for Cancer Survivors: Supporting Community-based Exercise Participation for Health Promotion and Secondary Cancer Prevention

The primary purpose of this proposed 5-year hybrid effectiveness and implementation study is to evaluate the relative benefit from, and implementation of an Alberta wide clinic-to-community-based cancer and exercise model of care - the Alberta Cancer Exercise (ACE) Program. The investigators hypothesize that the strategy will improve the physical well-being and QoL of survivors (on and off cancer treatment) while preventing the development of secondary cancers.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

A total of 2500 adult cancer survivors will be enrolled in the 5-year study. The investigators will build capacity by expanding ACE training and programming to sites beyond the large urban centers. The investigators plan for implementation in 7 Alberta YMCAs and/or City Recreation facilities within 3 years, as well as to formally establish partnerships within AHS to build further capacity across the province within existing AHS programming (e.g., CancerControl Rehab Services, Alberta Healthy Living Program and Primary Care Network). Virtual and supported home-based options will be available as an alternative.

Eligible and consenting participants will be screened for exercise safety, and following fitness testing will be triaged to appropriate exercise programming in their home or community. The exercise intervention will take place at the survivor's home, YMCAs and municipal fitness centres across the province. The supported home-based and community-based exercise program will be administered by exercise specialists who have undergone the ACE Cancer and Exercise: Training for Fitness Professionals course. Survivors will take part in a combination of aerobic, resistance, balance, and flexibility exercises delivered in a circuit-type class setting or group personal training format, twice weekly for an 8-to-12-week period.

Effectiveness outcomes include physical fitness, physical activity, quality of life, and healthcare utilization. These outcomes are known factors associated with the secondary prevention of cancer. The RE-AIM framework will be used to evaluate program reach, effectiveness, adoption, implementation and maintenance. The Alberta Quality Matrix for Health will serve as a framework to inform program sustainability beyond the funding period. Through this research, the investigators will better understand the effectiveness of the ACE program, and evaluate processes to support future implementation and sustainability.

Study Type

Interventional

Enrollment (Estimated)

2500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Alberta
      • Calgary, Alberta, Canada, T2N 1N4
        • Recruiting
        • University of Calgary/ Tom Baker Cancer Centre
        • Contact:
        • Principal Investigator:
          • Nicole Culos-Reed, PhD
      • Edmonton, Alberta, Canada, T6G 2G4
        • Recruiting
        • University of Alberta & Cross Cancer Institute
        • Principal Investigator:
          • Margaret L. McNeely, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. have a diagnosis of cancer;
  2. be over the age of 18 years;
  3. be able to participate in low-intensity levels of activity at minimum;
  4. be pretreatment, or receiving active cancer treatment (i.e., surgery, systemic therapy and radiation therapy), or have received cancer treatment within the past 3 years; or have ongoing significant cancer or treatment-related impairments (requiring supportive exercise intervention);
  5. be able to provide informed written consent in English.

Exclusion criteria:

1) Inability or deemed unsafe to participate in physical activity program

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise Intervention
Participant exercise sessions will be conducted in groups of 10-15 under the direct supervision of the community-based exercise specialist. Sessions will be twice a week for 12-weeks. Participants will have the option to continue with the exercise program after the 12-weeks on a fee-for-service basis.
Exercise sessions will include a combination of aerobic, resistance, balance, and flexibility exercises delivered in a circuit-type class setting or group personal training format.
Other Names:
  • Physical Activity

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical Activity Minutes Per Week
Time Frame: Baseline to One-year
Change in number of participants meeting Guidelines for Physical Activity of 150 minutes per week of moderate intensity exercise
Baseline to One-year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Aerobic Endurance
Time Frame: Baseline to One-year
Change in 6 minute walk test distance (metres)
Baseline to One-year
Quality of Life Cancer Specific
Time Frame: Baseline to One year
Change in Functional Assessment of Cancer Therapy General Scale
Baseline to One year
General Health-related Quality of Life
Time Frame: Baseline to One-year
Change in Rand Short Form (SF)-36
Baseline to One-year
Fatigue
Time Frame: Baseline to One-year
FACT-Fatigue subscale
Baseline to One-year
Upper extremity grip strength
Time Frame: Baseline to One-year
Change in hand-grip dynamometry (kg)
Baseline to One-year
Functional performance test
Time Frame: Baseline to One-year
Change in sit-to-stand (number in 30 seconds)
Baseline to One-year
Upper extremity flexibility
Time Frame: Baseline to One-year
Change in active shoulder flexion range of motion (degrees)
Baseline to One-year
Lower extremity flexibility
Time Frame: Baseline to One-year
Change in sit-and-reach test (cm)
Baseline to One-year
Balance
Time Frame: Baseline to One-year
Change in one legged stance test (seconds)
Baseline to One-year
Cost-effectiveness evaluation
Time Frame: Baseline to One-year
EQ-5D questionnaire
Baseline to One-year
Exercise adherence
Time Frame: Baseline to 12-weeks
Adherence to exercise programming (attendance at sessions)
Baseline to 12-weeks
Body Composition
Time Frame: Baseline to One-year
Change in BMI
Baseline to One-year
Waist and hip measurements
Time Frame: Baseline to One-year
Change in waist and hip circumference (cm) and change in waist-to-hip ratio
Baseline to One-year
Program implementation and evaluation
Time Frame: Baseline to One-year
RE-AIM: program reach, effectiveness, adoption, implementation and maintenance
Baseline to One-year
Adverse events
Time Frame: Baseline to One-year
Adverse event rates
Baseline to One-year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Home-based programming stepping test
Time Frame: Baseline to One-year
2-minute stepping test
Baseline to One-year
1RM or 8RM strength (optional)
Time Frame: Baseline to One-year
Change in bench press, vertical row and leg press strength (kg)
Baseline to One-year
Muscular endurance test (optional)
Time Frame: Baseline to One-year
Change in number of push-ups
Baseline to One-year
Core endurance test (optional)
Time Frame: Baseline to One-year
Change in plank test (seconds held)
Baseline to One-year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Margaret L McNeely, PT, PhD, University of Alberta
  • Principal Investigator: Nicole Culos-Reed, PhD, University of Calgary

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 9, 2017

Primary Completion (Estimated)

March 30, 2024

Study Completion (Estimated)

June 30, 2024

Study Registration Dates

First Submitted

December 2, 2016

First Submitted That Met QC Criteria

December 5, 2016

First Posted (Estimated)

December 6, 2016

Study Record Updates

Last Update Posted (Actual)

July 27, 2023

Last Update Submitted That Met QC Criteria

July 26, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • HREBA.CC-16-0905

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

No plan in place at this point in time.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neoplasms

Clinical Trials on Exercise

3
Subscribe